Northern Trust Corp Has $72.46 Million Position in Bath & Body Works, Inc. $BBWI

Key Points

• Northern Trust Corp increased its holdings in Bath & Body Works by 12.7% in Q1, acquiring an additional 269,508 shares, bringing its total ownership to approximately 2.39 million shares valued at $72.46 million.
• Bath & Body Works reported Q1 earnings of $0.49 per share, exceeding expectations while revenue was up 2.9% year-over-year, totaling $1.40 billion.
• A quarterly dividend of $0.20 was declared, translating to an annual yield of 2.6%, with the ex-dividend date set for August 22.

Northern Trust Corp increased its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 12.7% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,389,781 shares of the company's stock after acquiring an additional 269,508 shares during the quarter. Northern Trust Corp owned approximately 1.12% of Bath & Body Works worth $72,458,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. Golden State Wealth Management LLC increased its stake in shares of Bath & Body Works by 94.7% in the first quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company's stock valued at $40,000 after purchasing an additional 642 shares during the period. UMB Bank n.a. increased its stake in shares of Bath & Body Works by 65.9% during the first quarter. UMB Bank n.a. now owns 1,501 shares of the company's stock valued at $46,000 after acquiring an additional 596 shares during the period. Ancora Advisors LLC acquired a new position in shares of Bath & Body Works during the fourth quarter valued at approximately $67,000. GKV Capital Management Co. Inc. acquired a new position in shares of Bath & Body Works during the first quarter valued at approximately $69,000. Finally, Brooklyn Investment Group increased its stake in shares of Bath & Body Works by 394.9% during the first quarter. Brooklyn Investment Group now owns 2,697 shares of the company's stock valued at $82,000 after acquiring an additional 2,152 shares during the period. Institutional investors and hedge funds own 95.14% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts recently commented on the stock. Citigroup lowered their price objective on shares of Bath & Body Works from $42.00 to $40.00 and set a "buy" rating on the stock in a research note on Tuesday, August 19th. Piper Sandler set a $39.00 price target on shares of Bath & Body Works and gave the stock an "overweight" rating in a research report on Thursday, May 15th. Telsey Advisory Group reaffirmed an "outperform" rating and issued a $38.00 price target on shares of Bath & Body Works in a report on Thursday. JPMorgan Chase & Co. upped their price target on Bath & Body Works from $40.00 to $46.00 and gave the company an "overweight" rating in a report on Monday, July 28th. Finally, Wells Fargo & Company upped their price target on Bath & Body Works from $40.00 to $44.00 and gave the company an "overweight" rating in a report on Wednesday, May 14th. Fourteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, Bath & Body Works has a consensus rating of "Moderate Buy" and a consensus price target of $42.53.

Bath & Body Works Price Performance

Bath & Body Works stock traded down $2.08 during midday trading on Thursday, reaching $29.47. The stock had a trading volume of 17,266,529 shares, compared to its average volume of 4,970,217. The firm's fifty day simple moving average is $30.61 and its two-hundred day simple moving average is $30.86. Bath & Body Works, Inc. has a twelve month low of $24.94 and a twelve month high of $41.87. The firm has a market cap of $6.24 billion, a price-to-earnings ratio of 7.86, a PEG ratio of 1.06 and a beta of 1.54.

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its quarterly earnings data on Thursday, August 28th. The company reported $0.37 EPS for the quarter, hitting analysts' consensus estimates of $0.37. Bath & Body Works had a net margin of 11.10% and a negative return on equity of 47.44%. The firm had revenue of $1.55 billion during the quarter, compared to analyst estimates of $1.55 billion. During the same quarter last year, the business posted $0.37 EPS. The company's revenue was down .8% on a year-over-year basis. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. As a group, sell-side analysts predict that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, September 5th. Shareholders of record on Friday, August 22nd will be paid a dividend of $0.20 per share. The ex-dividend date of this dividend is Friday, August 22nd. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.7%. Bath & Body Works's dividend payout ratio (DPR) is 21.33%.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.